Fujifilm has invested $2 billion to build the largest cell culture biopharma CDMO facility in the United States and create 725 jobs. Holly Springs, North Carolina has been chosen as the site and the facility will be designed and built with sustainability as its core. It will offer large-scale cell culture manufacturing of bulk drug substance production with 8 x 20,000L bioreactors with the potential to add a further 24 x 20,000L bioreactors based on market demand. The facility will also provide commercial scale, automated fill-finish and assembly, packaging, and labelling services. | https://www.biospectrumasia.com/news/89/17799/fujifilm-invests-2-b-to-build-largest-cell-culture-biopharma-cdmo-facility-in-us.html